Panome Bio Enhances Multi-Omic Services with New Transcriptomics Offering

Panome Bio Enhances Multi-Omic Discovery Suite with Transcriptomics



Panome Bio continues to lead in providing comprehensive multi-omic services by unveiling its latest addition—transcriptional profiling. This strategic enhancement significantly strengthens their existing suite of discovery tools, already well-regarded by researchers worldwide.

Located in St. Louis, on May 28, 2025, Panome Bio announced that this new offering includes a full-service RNA sequencing workflow. Specifically designed for biomarker discovery and mechanism of action studies, this service seamlessly integrates with the company’s metabolomics and proteomics assays. The approach allows researchers to explore complex biological questions in a more cohesive manner, which is especially beneficial during the discovery research phase and early clinical trials.

Edward Weinstein, the CEO of Panome Bio, describes the company's innovative mindset by emphasizing, “At Panome Bio, we understand the importance of integrating multiple layers of information to gain a complete understanding of biological processes.” This comprehensive perspective is crucial for researchers aiming to unravel intricate biological dynamics.

The newly introduced transcriptomics service stands out thanks to its unique capabilities. It encompasses a complete RNAseq solution while maintaining a streamlined workflow, from sample preparation all the way through to data analysis. The analytical process covers aspects such as differential expression, pathway analysis, and expert data interpretation, providing clients with thorough insights into their findings.

Moreover, this transcriptional profiling service is user-friendly, requiring minimal sample inputs, and offers customized workflows that cater to a wide variety of sample types. This flexibility makes it an excellent choice for large cohort studies, where scalability is essential.

Through the integration of gene expression data with metabolomics and proteomics profiles, researchers are equipped to improve biomarker discovery processes. It facilitates a better understanding of biological pathways, ultimately enhancing confidence in their research findings. By combining diverse data types, Panome Bio is paving the way for groundbreaking advancements in the scientific field.

In addition to transcriptomics, Panome Bio excels in metabolomics and proteomics, establishing itself as a comprehensive contract research organization. This robust portfolio aids clients in disease understanding and drug development through a holistic analysis approach, combining different omics layers.

Researchers interested in leveraging Panome Bio's capabilities can take advantage of their comprehensive workflow, which includes experimental design, sample preparation, extensive analysis, and meticulous data processing. For further details about the services offered, prospective clients are encouraged to visit the company’s website, follow them on LinkedIn, or directly contact their marketing department.

In conclusion, the launch of transcriptomics not only enhances Panome Bio’s service offerings but also marks a significant advancement in the multi-omic landscape. As the demand for integrated data analysis continues to rise in the scientific community, Panome Bio is poised to remain at the forefront of innovation and support for researchers worldwide.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.